Maryland neurodegenerative disease therapy firm raises $10.5M in equity funding

PILLS MONEY cost opioid
Here's a look at some of the latest deals in healthcare. (Pixabay)

Neurodegenerative disease therapies, population health and a company making drugs for dry eye were among health companies in the U.S. that are in the midst of or closed fundraising rounds in the last week.

Curious about who is raising money? Here are some of the latest deals in healthcare: 

  • Germantown, Maryland-based Neuraly Inc., a company that is working on therapeutics for neurodegenerative diseases including Parkinson's and Alzheimer's, raised $10.5 million in equity funding. The CEO of the company is Seulki Lee, an assistant professor of radiology, ophthalmology and materials science and engineering and a member of the Johns Hopkins Kimmel Cancer Center. The company did not specify what the funding is for. 
     
  • Vera Whole Health, a Seattle-based firm that provides population health management to large- and midsized employers through on-site primary care, raised $5 million. They told the Puget Sound Business Journal they plan to use the funding to expand into new markets. 
     
  • Tear Film Innovations Inc., an early-stage San Diego company focused on developing products for treating evaporative dry eye and related symptoms, raised $8.5 million. They did not specify what the funding will be used for.
     
  • Newton, Massachusetts-based Cheetah Medical Inc., which makes noninvasive hemodynamic monitoring devices using an algorithm designed to allow physicians to examine a patient’s full hemodynamic profile, raised $7 million. Cheetah Medical said 16 unnamed investors participated in the round, according to Mass Device.

Have a recent healthcare funding announcement you'd like to share? Email Tina Reed with the details.

Innovation Awards

Submit your nominations for the FierceHealthcare Innovation Awards

The FierceHealthcare Innovation Awards showcases outstanding innovation that is driving improvements and transforming the industry. Our expert panel of judges will determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry. Deadline for submissions is this Friday, October 18th.

Suggested Articles

There may be a path to universal coverage without needing a single-payer overhaul, a new report shows. 

Genealogy company Ancestry is expanding into genetic health testing, ramping up competition with 23andMe.

Physician-led ACOs generated nearly seven times more savings in 2018 than ACOs led by hospitals, a new analysis finds.